Fibromyalgia syndrome and temporomandibular disorders with muscular pain. A review

References

• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders; 2nd edition. Cephalalgia. 2004;24:1–160.
   Web of Science ®Google Scholar
• Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA. Patient perspectives on the impact of fibromyalgia. Patient. Patient Educ Couns. 2008;73:114–20.
   PubMed Web of Science ®Google Scholar
• Choy EH, Mease PJ. Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheum Dis Clin North Am. 2009;35:329–37.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Clauw DJ, McCarberg BH, Fibro Collaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011;86:457–64.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smyte HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthrit Rheumatol. 1996;33:160–72.
   Web of Science ®Google Scholar
• Wolfe F, Claw DJ, Fitzcharles MA. The American College of Rheumatology preliminary diagnostic criteria for Fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600–10.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Moreno-Fernandez AM, DE Miguel M, Bonal P, Campa F, Jiménez-Jiménez LM, et al. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem. 2009;42:732–5.
   PubMed Web of Science ®Google Scholar
• Cordero MD, de Miguel M, Moreno-Fernández AM, Carmona Lopez MI, Garrido Maraver J, Cotán D, et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of Fibromyalgia patients: implication in the pathogenesis of the disease. Arthrit Res Ther. 2010;12:1174–6.
   Web of Science ®Google Scholar
• Buskila D. Fibromyalgia: a biopsychosocial syndrome. Isr Med Assoc J. 2003;5:887–8.
   PubMed Web of Science ®Google Scholar
• McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:403–25.
   PubMed Web of Science ®Google Scholar
• Peleg R, Ablin JN, Peleg A, Neumann L, Rabia RA, Buskila D. Characteristics of fibromyalgia in Muslim Bedouin women in a primary care clinic. Semin Arthrit Rheumat. 2008;37:398–402.
   PubMed Web of Science ®Google Scholar
• Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthrit Rheumat. 2010;39:448–53.
   PubMed Web of Science ®Google Scholar
• Jin H, Patil PM, Sharma A. Topical review: the enigma of fibromyalgia. J Oral Facial Pain Headache. 2014;28:107–18.
   PubMed Web of Science ®Google Scholar
• Boscato N, Almeida RC, Koller CD, Presta AA, Goettems ML. Influence of anxiety on Temporomandibular disorders-an epidemiological survey with elders and adults in Southern Brazil. J Oral Rehabil. 2013;40:643–9.
   PubMed Web of Science ®Google Scholar
• Köhler AA, Hugoson A, Magnusson T. Clinical signs indicative of temporomandibular disorders in adults: time trends and associated factors. Swedish Dental J. 2013;37:1–11.
   PubMed Web of Science ®Google Scholar
• UÇcar D, DiraÇoglu D, Karan A. Temporomandibular dysfunction syndrome: a prospective study of 255 consecutive patients. J Int Med Res. 2013;41:804–8.
   PubMed Web of Science ®Google Scholar
• Schmid-Schwap M, Bristela M, Kundi M, Piehslinger E. Sex-specific differences in patients with temporomandibular disorders. J Orofacial Pain. 2013;27:42–50.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam R, de Leeuw R, Zhu H, Nickerson RB, Okeson JP, Carlson CR. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2007;104:204–16.
   Web of Science ®Google Scholar
• Salvetti G, Manfredini D, Bazzichi L, Bosco M. Clinical features of the stomatognathic involvement in fibromyalgia syndrome: a comparison with temporomandibular disorders patients. Cranio. 2007;25:127–33.
   PubMed Web of Science ®Google Scholar
• Pimentel MJ, Gui MS, Martins de Aquino LM, Rizzatti-Barbosa CM. Features of temporomandibular disorders in fibromyalgia syndrome. Cranio. 2013;31:40–5.
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Fricton J, Carlson P, Messner R. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol. 2003;30:1841–5.
   PubMed Web of Science ®Google Scholar
• Leblebici D, Pektas ZO, Ortancil O, Hürcan EC, Bagis S, Akman MN. Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes. Rheumatol Int. 2007;27:541–4.
   PubMed Web of Science ®Google Scholar
• Thorp JN, Ritzline PD. Fibromyalgia is not a predictor variable for a successful outcome following surgical correction of internal derangement of the temporomandibular joint. J Oral Maxillofac Surg. 2011;69:19–27.
   PubMed Web of Science ®Google Scholar
• Fraga BP, Santos EB, Farias JP, Macieira JC, Quintans LJ, Onofre AS, et al. Signs and symptoms of temporomandibular dysfunction in fibromyalgic patients. J Craniofacial Surg. 2012;23:615–18.
   PubMed Web of Science ®Google Scholar
• Fricton JR. The relationship of temporomandibular disorders and fibromyalgia: implications for diagnosis and treatment. Curr Pain Headache Rep. 2004;8:355–63.
   PubMedGoogle Scholar
• Velly AM, Look JO, Shiffman E, Lenton PA, Kang W, Messner RP, et al. The effect of fibromyalgia and widespread pain on the clinically significant temporomandibular muscle and joint pain disorders: a prospective 18-month cohort study. J Pain. 2010;11:1155–64.
   PubMed Web of Science ®Google Scholar
• Nobrega JC, Siqueira SR, Siqueira JT, Teixeira MJ. Diferential diagnosis in a typical facial pain: a clinical study. Arq Neuropsiquiatr. 2007;65:256–61.
   PubMed Web of Science ®Google Scholar
• Da Silva LA, Kazyiama HH, de Siqueira JT, Teixeira MJ, de Siqueira SR. High prevalence of orofacial complaints in patients with fibromyalgia: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e29–34.
   PubMedGoogle Scholar
• Sloberg L, Carlson CR, Crofford LJ, de Leeuw R, Segestrom SC. Self-regulatory deficits in fibromyalgia and temporomandibular disorders. Pain. 2010;151:37–44.
   PubMed Web of Science ®Google Scholar
• Karibe H, Goddard G, Mcneill C, Shih ST. Comparison of patients with orofacial pain of different diagnostic categories. Cranio. 2011;29:138–43.
   PubMed Web of Science ®Google Scholar
• Schneider MJ. Tender point/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis. J Manipul Physiol Ther. 1995;18:398–406.
   PubMed Web of Science ®Google Scholar
• Pfau DB, Rolke R, Nickel R, Treede RD, Daublaender M. Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome. Pain. 2009;147:72–83.
   PubMed Web of Science ®Google Scholar
• Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorder. Arch Intern Med. 2000;160:221–7.
   PubMed Web of Science ®Google Scholar
• Alonso-Blanco C, Fernández de las Peñas C, De la Llave Rincon AI, Zarco P, Galán F, Svensson P. Characteristics of referred muscle pain to the head from active trigger points in women with myofascial temporomandibular pain and fibromyalgia syndrome. J Headache Pain. 2012;13:625–63.
   PubMed Web of Science ®Google Scholar
• Manfredini D, Tognini F, Montagnani G, Bazzichi L, Bombardieri S, Bosco M. Comparison of masticatory dysfunction in temporomandibular disorders and fibromyalgia. Minerva Stomatologica. 2004;53:641–50.
   PubMedGoogle Scholar
• Dawson A. Experimental tooth clenching. A model for studying mechanisms of muscle pain. Swedish Dental J Suppl. 2013;228:9–94.
   Google Scholar
• Guo W, Wang H, Zou S, Wei F, Dubner R, Ren K. Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain. Mol Pain. 2010;15(6):40.
   Google Scholar
• Okamoto K, Kimura A, Donishi T, Imbe H, Nishie Y, Matsushita H, et al. Contribution of peripheral 5-HT2A or 5-HT3 receptors to Fos expression in the trigeminal spinal nucleus produced by acute injury to the masseter muscle during persistent temporomandibular joint inflammation in rats. Neuroscience. 2006;143:597–606.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kimura A, Donishi T, Imbe H, Tamai Y. Central serotonin 3 receptors play an important role in the modulation of nociceptive neural activity of trigeminal subnucleus caudalis and nocifensive orofacial behavior in rats with persistent temporomandibular joint inflammation. Neuroscience. 2005;135:569–81.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Imbe H, Tashiro A, Kimura A, Donishi T, Tamai Y, Senba E. The role of peripheral 5HT2A and 5HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation. Neuroscience. 2005;130:465–74.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Imbe H, Tashiro A, Kunabe S, Senba E. Blockade of peripheral 5HT3 receptor attenuates the formalin-induced nocifensive behavior in persistent temporomandibular joint inflammation of rats. Neurosci Lett. 2004;367:259–63.
   PubMed Web of Science ®Google Scholar
• Oliveira MC, Clemente JT, Teixeira JM, Torres KE, Parada CA, Tambeli CH. 5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local Beta adrenoceptors. Pharmacol Biochem Behav. 2012;102:458–64.
   PubMed Web of Science ®Google Scholar
• Alstergren P, Kopp S. Pain and synovial fluid concentration of serotonin in arthritic temporomandibular joints. Pain. 1997;72:137–43.
   PubMed Web of Science ®Google Scholar
• Alstergren P, Kopp S, Theodorsson E. Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1 beta and serotonin. Acta Odontol Scand. 1999;57:16–22.
   PubMed Web of Science ®Google Scholar
• Kopp S. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg. 1998;56:189–91.
   PubMed Web of Science ®Google Scholar
• Rodríguez LL, Oliveira MC, Pelegrini da Silva A, de Arruda MC, Parada AC, Tambeli CH. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain. 2006;7:929–36.
   PubMed Web of Science ®Google Scholar
• Ting E, Roveroni RC, Ferrari LF, Lotufo CM, Veiga MC, Parada CA, Tambeli CH. Indirect mechanism of histamine-induced nociception in temporomandibular joint of rats. Life Sci. 2007;81:765–71.
   PubMed Web of Science ®Google Scholar
• Fredriksson L, Alstergren P, Kopp S. Serotonergic mechanisms influence the response to glucocorticoid treatment in TMJ arthritis. Mediators Inflamm. 2005;2005(4):194–201.
   PubMed Web of Science ®Google Scholar
• Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis. Mediators Inflamm. 2004;13:373–6.
   PubMed Web of Science ®Google Scholar
• Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S. Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life Sci. 2000;68:591–602.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Radiol Endodontics. 2002;94:328–32.
   PubMed Web of Science ®Google Scholar
• Meloto CB, Serrano PO, Ribeiro-Dasilva MC, Rizzatti-Barbosa CM. Genomics and the new perspectives for temporomandibular disorders. Arch Oral Biol. 2011;56:1181–91.
   PubMed Web of Science ®Google Scholar
• Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA. T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis. 2004;10:349–52.
   PubMed Web of Science ®Google Scholar
• Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, Oz F, Güray E. Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. Am J Orthodontics Dentofacial Ortho. 2001;120:308–13.
   PubMed Web of Science ®Google Scholar
• Ojima K, Watanabe N, Narita N, Narita M. Temporomandibular disorders is associated with a serotonin transporter gene polymorphism in the Japanese population. Bio Psycho Social Med. 2007;10(1):3.
   Google Scholar
• Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306:686–8.
   PubMed Web of Science ®Google Scholar
• Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthrit Rheumat. 2008;37:339–52.
   PubMed Web of Science ®Google Scholar
• Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23:611–15.
   PubMed Web of Science ®Google Scholar
• Staud R. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002;4:299–305.
   PubMedGoogle Scholar
• Alnigenis MNY, Barland P. Fibromyalgia syndrome and serotonin. Clin Exp Rheumatol. 2001;19:205–10.
   PubMed Web of Science ®Google Scholar
• Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N, et al. Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis. 2002;11:434–42.
   PubMed Web of Science ®Google Scholar
• Russell IJ. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthrit Rheumat. 1994;37:1593–601.
   PubMed Web of Science ®Google Scholar
• Napadow V, LaCount L, Park K, As-Sanie S, Claw DJ, Harris RE. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthrit Rheumat. 2010;62:254–5.
   Web of Science ®Google Scholar
• Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257(2):139–55.
   PubMed Web of Science ®Google Scholar
• Ru-Rong X, Zhen-Zhong X, Yong-Jing G. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533–48.
   PubMed Web of Science ®Google Scholar
• Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130.
   PubMedGoogle Scholar
• Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol. 1984;11:808–13.
   PubMed Web of Science ®Google Scholar
• Sprott H, Salemi S, Gay RE, Bradley LA, Alarcón GS, Oh SJ, et al. Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibers. Ann Rheum Dis. 2004;63:245–51.
   PubMed Web of Science ®Google Scholar
• Drewes AM, Andreasen A, Schrøder HD, Høgsaa B, Jennum P. Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study. Br J Rheumatol. 1993;32:479–83.
   PubMedGoogle Scholar
• Bajwa R, Jay WM, Asconapé J. Neuro-ophthalmologic manifestations of epilepsy. Semin Ophthalmol. 2006;21(4):255–61.
   PubMedGoogle Scholar
• Jackson MJ, O'Farrell S. Free radicals and muscle damage. Br Med Bull. 1993;49:630–41.
   PubMed Web of Science ®Google Scholar
• Eisinger J, Gandolfo C, Zakarian H, Ayavou TJ. Reactive oxygen species, antioxidant status and Fibromyalgia. Musculoskeletal Pain. 1997;5:5–1.
   Web of Science ®Google Scholar
• Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep. 2006;11:131–5.
   PubMed Web of Science ®Google Scholar
• Akkus S, Naziroglu M, Eris S, Yalman K, Yilmaz N, Yener M. Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Func. 2009;27:181–5.
   PubMed Web of Science ®Google Scholar
• Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005;25:188–90.
   PubMed Web of Science ®Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2006;26:598–603.
   PubMed Web of Science ®Google Scholar
• Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exper Mol Pathol. 2007;83:84–92.
   PubMed Web of Science ®Google Scholar
• Altindag O, Gur A, Calgan N, Soran N, Celik H, Selek S. Paraoxonase and arylesterase activities in fibromyalgia. Redox Rep. 2007;12:134–8.
   PubMed Web of Science ®Google Scholar
• Kaufmann I, Schelling G, Eisner C, Richter HP, Krauseneck T, Vogeser M, et al. Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology. 2008;33:676–85.
   PubMed Web of Science ®Google Scholar
• Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M. Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int. 2009;29:629–33.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Alcocer-Gomez E, Cano-García FJ, de Miguel M, Carrión AM, Navas P, Sánchez-Alcazar JA. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One. 2011;6:e26915.
   PubMedGoogle Scholar
• Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L, et al. ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem. 2008;41:1084–90.
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther. 2004;309:869–78.
   PubMed Web of Science ®Google Scholar
• Manuel y Keenoy B, Moorkens G, Vertommen J, De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001;68:2037–49.
   PubMed Web of Science ®Google Scholar
• Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003;335:151–4.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Cano-García FJ, Alcocer-Gomez E, de Miguel M, Sánchez-Alcázar JA. Oxidative stress correlates with headache symptoms in fibromialgia: coenzyme Q10 effect on clinical improvement. PLoS One. 2012;7:e35677.
   PubMed Web of Science ®Google Scholar
• Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull. 1993;49:577–87.
   PubMed Web of Science ®Google Scholar
• Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. Short-term effect of glucocorticoid injection into the superficial masseter muscle of patients with chronic myalgia: a comparison between fibromyalgia and localized myalgia. J Orofacial Pain. 1997;11:249–57.
   PubMedGoogle Scholar
• Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. Effect of local glucocorticoid injection on masseter muscle level of serotonin in patients with chronic myalgia. Acta Odontol Scand. 1998;56:129–34.
   PubMed Web of Science ®Google Scholar
• Ernberg M, Hedenberg-Magnusson B, Alstergren P, Lundeberg T, Kopp S. Pain, allodynia, and serum serotonin level in orofacial pain of muscular origin. J Orofacial Pain. 1999;13:56–62.
   PubMedGoogle Scholar
• Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci. 1999;65:313–25.
   PubMed Web of Science ®Google Scholar
• Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand. 2001;59:348–55.
   PubMed Web of Science ®Google Scholar
• Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001;64:43–51.
   PubMed Web of Science ®Google Scholar
• Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W. Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain. 2009;10:542–52.
   PubMed Web of Science ®Google Scholar
• Gui MS, Pedroni CR, Aquino LM, Pimentel MJ, Alves MC, Rossini S, et al. Facial pain associated with fibromyalgia can be marked by abnormal neuromuscular control: a cross-sectional study. Physical Ther. 2013;93:1092–101.
   PubMed Web of Science ®Google Scholar
• Woda A, L'heveder G, Ouchchane L, Bodéré C. Fatigue mediates the relationship between pain interference and distress in patients with persistent orofacial pain. J Oral Facial Pain Headache. 2013;14:455–66.
   Google Scholar